Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Smoking Cessation Intervention for Early-Stage Lung Cancer Survivors
NCT00032084Phase 3Terminated
- Sponsor
- SWOG Cancer Research Network
- Start
- Jan 2002
- Primary completion
- Feb 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of bupropion in Tobacco Use Disorder (TUD), sponsored by SWOG Cancer Research Network. Started Jan 2002; status: terminated.
02
Drugs
bupropion
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00032084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00032084.